Integrated BioPharma Reports Results for its Quarter and Fiscal Year Ended June 30, 2026
HILLSIDE, NJ / / September 25, 2026 / Integrated BioPharma, Inc. OTC:INBP (the "Company" or "INBP") reports its financial results for the quarter and fiscal year ended June 30, 2026.Revenue for the quarter ended June 30, 2026 was $9.8 million compared to $14.2 million for the quarte…